-
-
-
-
-
-
-
CUMBERLAND PHARMACEUTICALS REPORTS Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE
-
-
-
-
-
-
-
Joint U.S. Commercialization of RedHill's Talicia® Commences
-
-
-
-
-
-
-
Cumberland Pharmaceuticals (CPIX) Receives FDA Orphan Drug Designation and Rare Pediatric Disease Designation for Ifetroban
-
-
-
-
-
-
-
Cumberland Pharmaceuticals (CPIX) Announces FDA Clearance of IND for Treatment of Idiopathic Pulmonary Fibrosis
-
-
-
-
-
-
-
Cumberland Pharmaceuticals (CPIX) Announces Key Co-Promotion Agreement with Verity Pharmaceuticals to Expand Support for Sancuso
-
-
-
-
-
-
-
Cumberland Pharmaceuticals Reports Third Quarter 2021 Financial Results & Company Update
-
-
-
-
-
-
-
Cumberland Pharmaceuticals Reports 14% Revenue Growth In The Second Quarter
-
1,160,041 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

